ReviewFrontiers in neurology
Pediatric parkinsonism: clinical review and a proposed clinical algorithm.
Review in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric parkinsonism (PP) is a rare but disabling movement disorder characterized by bradykinesia and rigidity, with tremor being less frequent. Additional features include gait disturbances and impaired postural reflexes. In younger children, hypotonia is often a predominant sign. Clinical expression evolves with neurodevelopment and is frequently associated with other movement abnormalities, such as dystonia. The condition may arise from a variety of pathophysiological mechanisms and multiple etiologies, with genetic causes being particularly prominent. A classification system has been proposed based on age of onset, clinical features, prognosis and etiology, comprising: Developmental parkinsonism, Infantile degenerative parkinsonism, Parkinsonism in the setting of postnatal neurodevelopmental disorders, Parkinsonism associated with multisystemic brain diseases, Juvenile parkinsonism and dystonia-parkinsonism and Acquired parkinsonism. A specific assessment tool-the Infantile Parkinsonism-Dystonia Rating Scale-has recently been developed and primarily validated to quantify severity, monitor disease progression and assess treatment response. This review aims to provide a comprehensive overview of the clinical features, pathophysiology, etiologies and treatment approaches of pediatric parkinsonism. In addition, we propose a diagnostic algorithm to support clinical decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.